Clinical Research Directory
Browse clinical research sites, groups, and studies.
The Prognostic Value of Biomarkers and the Effect of Tolperisone in Acute Low Back Pain and Sciatic Pain "BETA"
Sponsor: Semmelweis University
Summary
The main purpose of the trial is to identify biomarkers from the blood as well as electrophysiologic and morphometric features (chemical, electrophysiologic and ultrasound biomarkers) that reflect the intensity of pain and/or foretell the efficacy of pharmacological (non-surgical) treatment in patients with acute low back pain.
Official title: The Prognostic Value of Biomarkers and the Effect of Tolperisone in Acute Low Back Pain -BETA. A Phase 3 Investigator Initiated Study
Key Details
Gender
All
Age Range
18 Years - 80 Years
Study Type
INTERVENTIONAL
Enrollment
150
Start Date
2019-12-13
Completion Date
2024-06-30
Last Updated
2024-04-17
Healthy Volunteers
Yes
Conditions
Interventions
Tolperisone Hydrochloride
Tolperisone Hydrochloride tablets of 150 mg, administered three times a day
Placebo
matching placebo administered three times a day
Locations (1)
Department of Neurology, Semmelweis University
Budapest, Hungary